San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down ...
With a market capitalization approaching the $1 trillion mark, Eli Lilly is engaged in a close competitive race with Novo Nordisk for dominance in the obesity treatment sector. Market researchers ...
The new "triple agonist" weight loss medication called retatrutide can help people lose an average of 28.7 percent of ...
In November, the Trump administration resurrected a Most Favored Nation (MFN) reference pricing policy, which would tie drug ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
In this video, Jonathan A. Bernstein, MD, discusses findings about chronic itch presented at the American College of Allergy, ...
Meanwhile, people with overweight or obesity lost up to 11.3% more weight than placebo by week 36 with a novel GLP-1 agonist ...
15h
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs
Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.
Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results